Kun Su Mok

HMP Law
Managing Partner, Corporate Practice Group
Email: mokks@hmplaw.com
Phone: (82) 2 772 2702
Jurisdiction:
South Korea
Experience / Expertise:
Alt' Investments (inc' Private Equity)
Corporate / Mergers & Acquisitions
International Trade
Investigations & Due Diligence
Life Sciences/Healthcare
Restructuring & Insolvency

Kun Su Mok is one of the founding partners (and current managing partner) of HMP Law and heads the firm’s Corporate & Business Consulting Group and Pharmaceuticals & Healthcare Group. Some of his representative matters include advising Merck Sharpe & Dohme, AstraZeneca, Gilead, Johnson & Johnson/Janssen, Siemens and Olympus in regulatory and commercial issues in the Korean pharmaceutical industry through their joint ventures and/or local subsidiaries; advising multiple Emerson group subsidiaries in all corporate legal matters; SunEdison/MEMC in their business operations through multiple joint venture and subsidiary entities in Korea; and advising Korea Foreign Schools Foundation and Yongsan International School of Seoul in their establishment and operations. He has been admitted to both the Korean and the New York State bars.

Kun Su Mok practice covers the following areas:
•    Antitrust and Fair Trade
•    Business Consulting
•    Corporate Governance
•    Corporate Restructuring and Bankruptcy
•    Distributorships and Franchising
•    Foreign Exchange
•    Foreign Investment
•    Joint Ventures
•    Mergers and Acquisitions
•    Pharmaceuticals and Healthcare